INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET
The definitions the concepts of “innovations” and “innovation process” have been adduced, general assessment of the position of the Russian Federation in the world in terms of investment in scientific and technical research and developments (R & D) has been given, the most investment areas i...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Publishing House of the State University of Management
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34010ebfa02f48d1ad80109cb631e7f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:34010ebfa02f48d1ad80109cb631e7f5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:34010ebfa02f48d1ad80109cb631e7f52021-12-03T07:43:33ZINNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET1816-42772686-841510.26425/1816-4277-2020-8-57-64https://doaj.org/article/34010ebfa02f48d1ad80109cb631e7f52020-09-01T00:00:00Zhttps://vestnik.guu.ru/jour/article/view/2348https://doaj.org/toc/1816-4277https://doaj.org/toc/2686-8415The definitions the concepts of “innovations” and “innovation process” have been adduced, general assessment of the position of the Russian Federation in the world in terms of investment in scientific and technical research and developments (R & D) has been given, the most investment areas in terms of the volume of expenditures on scientific and technical research and development (R & D) have been highlighted . Key arguments that justify the need for innovative development of the pharmaceutical industry in Russia have been presented. The state and structure of the pharmaceutical market in Russia have been considered, the factors of transition of the pharmaceutical industry to an innovative course of development have been specified. Clear results of the implementation of the strategy for the development of the pharmaceutical industry until 2020 have been emphasized. Examples of implementation of the innovation management mechanism at the level of a separate domestic company Biocad have been given.E. A. BykovaPublishing House of the State University of Managementarticledevelopment of the pharmaceutical industryelaboration of the pharmaceutical industryinnovationsinnovative factorsmedicinespharmaceutical industrypharmacy in russiascientific and technical researchSociology (General)HM401-1281Economics as a scienceHB71-74RUВестник университета, Vol 0, Iss 8, Pp 57-64 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
development of the pharmaceutical industry elaboration of the pharmaceutical industry innovations innovative factors medicines pharmaceutical industry pharmacy in russia scientific and technical research Sociology (General) HM401-1281 Economics as a science HB71-74 |
spellingShingle |
development of the pharmaceutical industry elaboration of the pharmaceutical industry innovations innovative factors medicines pharmaceutical industry pharmacy in russia scientific and technical research Sociology (General) HM401-1281 Economics as a science HB71-74 E. A. Bykova INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
description |
The definitions the concepts of “innovations” and “innovation process” have been adduced, general assessment of the position of the Russian Federation in the world in terms of investment in scientific and technical research and developments (R & D) has been given, the most investment areas in terms of the volume of expenditures on scientific and technical research and development (R & D) have been highlighted . Key arguments that justify the need for innovative development of the pharmaceutical industry in Russia have been presented. The state and structure of the pharmaceutical market in Russia have been considered, the factors of transition of the pharmaceutical industry to an innovative course of development have been specified. Clear results of the implementation of the strategy for the development of the pharmaceutical industry until 2020 have been emphasized. Examples of implementation of the innovation management mechanism at the level of a separate domestic company Biocad have been given. |
format |
article |
author |
E. A. Bykova |
author_facet |
E. A. Bykova |
author_sort |
E. A. Bykova |
title |
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
title_short |
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
title_full |
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
title_fullStr |
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
title_full_unstemmed |
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET |
title_sort |
innovative processes in the russian pharmaceutical market |
publisher |
Publishing House of the State University of Management |
publishDate |
2020 |
url |
https://doaj.org/article/34010ebfa02f48d1ad80109cb631e7f5 |
work_keys_str_mv |
AT eabykova innovativeprocessesintherussianpharmaceuticalmarket |
_version_ |
1718373440042303488 |